Future Directions in Prostate Cancer Management: An Evolving Treatment Landscape
Closing out his discussion on prostate cancer, Michael S. Leapman, MD, MHS, highlights practical advice and shares hope for future improvements in the treatment landscape.
Improving Management of Prostate Cancer: The Decipher Prostate Genomic Classifier
Focused discussion on the Decipher Prostate Genomic Classifier and real-world data from the American Urological Association (AUA) Annual Meeting in the setting of prostate cancer management.
Overview of the Classification and Management of Prostate Cancer
Expert urologist Michael S. Leapman, MD, MHS, provides comprehensive insight to the classification of prostate cancer and current treatment modalities available to patients.
Opioid abuse: How it is impacting men’s health
"There are direct endocrine consequences of opioid use, including hypogonadism, that adversely impact men’s health," write Michael S. Leapman, MD, and Steven A. Kaplan, MD.
2 Clarke Drive Cranbury, NJ 08512